Liver factors involved in drug metabolism in experimentally infected rats: deleterious effect of ornithine alpha-ketoisocaproate.

[1]  P. Denis,et al.  Liver glutathione and cytochrome P450 activity in experimental infection: Study of the relative effects of infectious stress and malnutrition , 1991, Critical care medicine.

[2]  P. Denis,et al.  Rehabilitation of microsomal enzymes in malnourished rats: comparison of parenteral versus oral refeeding. , 1989, Clinical nutrition.

[3]  J. Fischer,et al.  Infusion of a branched-chain amino acid-enriched solution and alpha-ketoisocaproic acid in septic rats: effects on nitrogen balance and skeletal muscle protein turnover. , 1988, JPEN. Journal of parenteral and enteral nutrition.

[4]  C. McClain,et al.  Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice. , 1987, Life sciences.

[5]  F. Gonzalez,et al.  The induction of a specific form of cytochrome P-450 (P-450j) by fasting. , 1987, Biochemical and biophysical research communications.

[6]  P. Kamoun,et al.  Efficiency of substitution of 2-ketoisocaproic acid and 2-ketoisovaleric acid in the diet of normal and uremic growing rats. , 1986, The American journal of clinical nutrition.

[7]  A. Barbul,et al.  Intravenous hyperalimentation with high arginine levels improves wound healing and immune function. , 1985, The Journal of surgical research.

[8]  M. Schemper,et al.  Liver amino acids in sepsis. , 1985, Surgery.

[9]  T. Eling,et al.  The formation of aminopyrine cation radical by the peroxidase activity of prostaglandin H synthase and subsequent reactions of the radical. , 1985, The Journal of biological chemistry.

[10]  S. Wedel,et al.  Reprioritization of hepatic plasma protein release in trauma and sepsis. , 1985, Archives of surgery.

[11]  A. Goldberg,et al.  Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. , 1983, The New England journal of medicine.

[12]  A. Ghoneim,et al.  Serial C-reactive protein measurements in infective complications following cardiac operation: evaluation and use in monitoring response to therapy. , 1982, The Annals of thoracic surgery.

[13]  M. Walser,et al.  Growth of rats fed by a continuous intragastric infusion containing amino acids and keto acids. , 1982, The American journal of clinical nutrition.

[14]  M. Walser,et al.  Branched‐chain ketoacids reduce muscle protein degradation in duchenne muscular dystrophy , 1982, Muscle & nerve.

[15]  A. Goldberg,et al.  Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? , 1982, The Journal of biological chemistry.

[16]  P. White,et al.  Ketamine--its pharmacology and therapeutic uses. , 1982, Anesthesiology.

[17]  M. Rennie,et al.  Nitrogen estimation in biological samples by use of chemiluminescence. , 1980, Clinical chemistry.

[18]  D. Pessayre,et al.  Effect of fasting on metabolite-mediated hepatotoxicity in the rat. , 1979, Gastroenterology.

[19]  B. N. Ladu,et al.  Fundamentals of Drug Metabolism and Drug Disposition , 1979 .

[20]  J. Fischer,et al.  Amino Acid Derangements in Patients With Sepsis: Treatment With Branched Chain Amino Acid Rich Infusions , 1978, Annals of surgery.

[21]  P. Seglen.  Effects of amino acids, ammonia and leupeptin on protein synthesis and degradation in isolated rat hepatocytes. , 1978, The Biochemical journal.

[22]  J M Lyons,et al.  Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. , 1978, The Journal of clinical investigation.

[23]  G. Blackburn,et al.  Proteolysis associated with a deficit of peripheral energy fuel substrates in septic man. , 1976, Surgery.

[24]  G. Sutherland,et al.  CYSTEAMINE, METHIONINE, AND PENICILLAMINE IN THE TREATMENT OF PARACETAMOL POISONING , 1976, The Lancet.

[25]  D. Kipnis,et al.  Alanine and glutamine synthesis and release from skeletal muscle. I. Glycolysis and amino acid release. , 1976, The Journal of biological chemistry.

[26]  J. Kinney,et al.  Nonsuppressability of gluconeogenesis by glucose in septic patients. , 1976, Metabolism: clinical and experimental.

[27]  A. Braude,et al.  Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats. , 1974, The American journal of pathology.

[28]  R. Kato,et al.  Effect of starvation on the in vivo metabolism and effect of drugs in female and male rats. , 1967, Japanese journal of pharmacology.

[29]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[30]  P. Manson-Bahr.  Review of Infectious Diseases , 1962, Nature.

[31]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[32]  T NASH,et al.  The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. , 1953, The Biochemical journal.

[33]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  A. Gornall,et al.  Determination of serum proteins by means of the biuret reaction. , 1949, The Journal of biological chemistry.

[35]  M. Walser.  Therapeutic aspects of branched-chain amino and keto acids. , 1984, Clinical science.

[36]  I. Chaudry,et al.  Alterations in hepatic water and electrolyte balance in sepsis. , 1984, Archives of surgery.

[37]  F. Cerra,et al.  The physiologic recovery trajectory as the organizing principle for the quantification of hormonometabolic adaptation to surgical stress and severe sepsis. , 1979, Advances in shock research.

[38]  A. M. Lefer,et al.  Advances in shock research , 1979 .

[39]  G. Simpson,et al.  Thymoleptic and neuroleptic drug plasma levels in psychiatry: current status. , 1976, International review of neurobiology.

[40]  Thomas Stretch Dowse,et al.  MUSCLE AND NERVE , 1903 .